DeCure for Nonsyndromic congenital nail disorder 8
DeCure's autonomous Dermatology AI scientist is researching a drug-repurposing hypothesis for nonsyndromic congenital nail disorder 8 — screening already-approved drugs against its 1-gene Open Targets disease module to publish open-access research. Research is fast; the path to publication is funded in milestone stages.
Disease moduleNonsyndromic congenital nail disorder 8 maps to a 1-gene Open Targets module — the target space DeCure's AI scientist screens approved drugs against.
DeCure.ai methodSignature reversal (LINCS) plus network proximity (STRING) rank already-approved drugs likely to perturb this module — the same engine that produces DeCure.ai's repurposing hypotheses.
Repurposing thesisScreening approved medicines against this disease module, then publishing the evidence for the strongest candidate. Known pharmacology and human exposure data make the first question sharper — they do not establish safety or efficacy in a new indication.
Research record
01
ResearchComing soon
Candidate research + dossier — target rationale, drug-repurposing thesis and evidence pack.proof: Published dossier + on-chain hash
02
ValidationComing soon
In-vitro biological validation at a contract research org (CRO).proof: CRO contract + in-vitro report
03
Peer review & paperComing soon
Peer-reviewed paper published open-access (preprint + journal).proof: DOI + open-access link + on-chain hash
Current lead
No approved-drug candidate for nonsyndromic congenital nail disorder 8 is corroborated in the literature DeepSearch retrieved. Some conditions are managed with non-pharmacological care — a device, surgery or physical therapy — rather than a medicine; that may be the case here, or the literature we found may simply be too sparse yet to support a drug-repurposing angle.
What the evidence adds up to
No abstract in the provided set reports any treatment, trial, or outcome data for nonsyndromic congenital nail disorder 8. The three abstracts are general reviews or case series covering paediatric nail disorders broadly. One 2014 review notes that most published reports on paediatric nail diseases involve single cases and that diagnosis by non-experts is difficult. A 2024 review states that non-syndromic congenital nail disorders include anonychia, hyponychia, congenital malalignment of the great toenail, and racket thumbs, each with distinct genetic associations, but gives no numbers on prevalence, survival, or response to any intervention. A separate 2024 case series describes three patients with acquired congenital malalignment of the great toenail, aged in their 50s, 70s, and 80s, and mentions that drugs can cause nail changes, but provides no treatment outcomes.
No drug is named in any of these abstracts. No efficacy data, response rates, or survival figures are reported for any compound in relation to nonsyndromic congenital nail disorder 8. The literature cited consists entirely of descriptive reviews and a three-patient case series, none of which test a therapeutic agent.
What is missing is any clinical trial, any patient-level outcome data, any biomarker or stratification strategy, and any funding for a treatment study. Without a trial that measures a specific endpoint in a defined patient group, no drug can be evaluated for this disorder.
Evidence
Retrieved by DeepSearch across 234,678,978 indexed works and resolved on OpenAlex — ranked by citations, including the results that did not work.
Current Opinion in Pediatrics · 2014 · 33 citations
Nail disorders in infants and children
AbstractPURPOSE OF REVIEW: Nail diseases in infants and children are an uncommon cause of consultation and are often difficult to diagnose and to manage. This review will cover nail diseases that are most commonly seen in clinical practice, including congenital and hereditary disorders and inflammatory, infective, and neoplastic nail diseases. The purpose of the review is to help the reader to recognize nail disorders at an early age and to manage them appropriately. RECENT FINDINGS: Two recent large studies have reported the clinical findings of genetic disorders involving the nails, that is, pachyonychia congenita and epidermolysis bullosa. Only a few articles gave a comprehensive review of a disease, as occurred for onychomycosis, while the majority of the reports published in the recent literature involve single cases. SUMMARY: Nail diseases in children and neonates are not easy to diagnose by nonexperts. Basic knowledge of the anatomy and biology of the nail facilitates their diagnosis as the understanding of their pathophysiology. This review gives hints at the most common nail diseases that affect infants and children.
AbstractBackground: Pediatric nail disorders encompass a broad range of conditions. This article aimed to consolidate current knowledge on pediatric nail disorders to enhance diagnostic proficiency and clinical management among healthcare professionals. Summary: Pediatric nail disorders present a diagnostic challenge due to their diverse nature. Non-syndromic congenital nail disorders encompass various anomalies such as anonychia/hyponychia, congenital malalignment of the great toenail, and racket thumbs, each with distinct clinical presentations and genetic associations. Syndromic congenital nail disorders, often part of complex syndromes, are characterized by unique features and associated abnormalities. Acquired nail diseases in children, like Beau's lines and onychomadesis, typically result from trauma or infection, while melanonychia, although rare in children, requires careful monitoring for potential malignant alterations, with consideration for biopsy in cases with concerning features. Key Messages: (1) Pediatric nail disorders may pose diagnostic challenges and require a comprehensive understanding of nail anatomy and development. (2) Congenital nail disorders encompass isolated anomalies and syndromic associations, necessitating thorough evaluation for associated systemic conditions. (3) Acquired nail diseases may indicate underlying trauma or systemic illness and require careful assessment.(4) Melanonychia in children requires ongoing monitoring and evaluation, emphasizing the importance of consistent follow-up and histopathological examination when necessary.
SKIN The Journal of Cutaneous Medicine · 2024 · 1 citations · open access
Acquired Congenial Malalignment of the Great Toenails: A Case Series
AbstractCongenital malalignment of the great toenail is a dystrophic disorder that is characterized by lateral deviation of the nail plates. It is usually present at birth and diagnosed very early in life. Late onset of this condition, often referred to as, “acquired,” is very uncommon. Mechanical stress and repeated microtraumas to the nail can cause complications that can worsen the appearance of the nail and make the condition more obvious in older individuals, however, there are other triggers for this condition as well, such as drugs that can cause nail changes. Properly diagnosing this condition can prevent patients from undergoing unnecessary treatments and also facilitate the efficient initiation of the correct treatment in patients. Here, we discuss 3 cases of acquired congenital malalignment of the great toenail in patients during their 5th, 8th, and 7th decades of life.
Disease module: DeepOracle (Open Targets). Structures: RDKit from PubChem SMILES. Literature: retrieved by DeepSearch across 234,678,978 indexed works (targeted per-candidate search), resolved on OpenAlex.
DeCure is a research and publication project, not medical advice and not a treatment. "DeCure for X" describes a research goal, not a claim that a cure exists. Backing a cure is a contribution to fund the research — it is not an investment, and confers no yield, royalty, equity or IP ownership. Papers are published open-access by the DeCure.ai DAO.
